跳到正文
insitro· @insitro · X·· 2026-10-15精选AI 评分68
AI 导读

insitro 宣布与阿斯利康(AstraZeneca)就代谢功能障碍相关脂肪性肝炎(MASH)和心肌病的 AI 药物发现达成战略合作,将获得 4000 万美元前期付款,并有资格获得最高约 14.6 亿美元的发现、开发与商业化里程碑付款以及分级特许权使用费。

推荐理由

交易结构把前期发现与后期临床的分工写得具体,读者可据此理解 AI 制药合作如何分配风险与回报。

正文 · 原文

Today, insitro announced a strategic collaboration with @AstraZeneca for the AI-enabled discovery of novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) and cardiomyopathies.

insitro will receive $40 million upfront and is eligible for up to approximately $1.46 billion in potential, discovery, development and commercial milestones, plus tiered royalties.

Both diseases are defined by the problem the collaboration is built to address. In each case, a single diagnostic label spans patients whose underlying biology differs. The heterogeneity across these diseases has made them difficult to treat, and the condition under which insitro’s machine learning capabilities on human data is most useful.

Under the agreement, insitro will identify causal disease biology in both indications and advance AstraZeneca-nominated targets from discovery through to development candidate; AstraZeneca will lead clinical development, regulatory work, and commercialization.

“Partnering with AstraZeneca allows us to pair our deep biological precision with their deep pharmaceutical expertise and scale with potential for accelerated advancement of novel programs through development and to patients.” — @DaphneKoller, founder and CEO of insitro

Sharon Barr, Executive Vice President and Head of BioPharmaceuticals R&D, AstraZeneca: "Partnering with insitro, we are using AI to identify the biological drivers of disease to support the rapid discovery of high-quality novel molecules, advancing our ambition to deliver the next generation of medicines to patients faster.”

Read the announcement: https://www.insitro.com/news/insitro-announces-a-strategic-collaboration-with-astrazeneca-for-ai-enabled-discovery-of-novel-therapeutics-for-mash-and-cardiomyopathies/

More on our approach to causal biology: https://deepphenotype.substack.com
#AIDrugDiscovery #MASH #Cardiomyopathies

来源:insitro · x.com